Treatment compliance
diarrhoea
ADVERSE EVENTS, DISEASE, FEBRILE NEUTROPENIA
The reasons for treatment discontinuation were: progressive disease (PD)—7/18 patients, 39%; adverse events related to treatment (AZD8931 and/or FOLFIRI) - 4/18, 22%; (2 diarrhoea, 1 skin reaction, 1 febrile neutropenia); treatment delay of more than 3 weeks due to unrelated reasons - 4/18, 22%, patient choice - 2/18, 11% and adverse events not related to treatment - 1/18, 6%.